In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best performing healthcare stocks to buy now. On April 15, CNBC reported that President ...

At this time, I would like to welcome everyone to the Phibro Animal Health Corporation Third Quarter 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 ...

In recent trading, shares of Phibro Animal Health Corp. (Symbol: PAHC) have crossed above the average analyst 12-month target price of $21.25, changing hands for $22.25/share. When a stock reaches ...

Q1 2025 Adjusted EBITDA of $289,060 was a decrease of 30.0% over Q4 2024 Adjusted EBITDA of $412,947 and 20.1% over Q1 2024 Adjusted EBITDA of $361,802 (see calculation of Adjusted EBITDA below).

HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce ...

Activist Glenview cuts stake in CVS after strong first-quarter earnings Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health following the insurer's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Phibro Animal Health Corporation reported strong financial results for Q3 2025, exceeding both earnings and revenue forecasts. The company posted an adjusted diluted EPS of $0.63, surpassing the ...